Cantor Fitzgerald reiterates Tesla stock rating on Europe FSD approval By Investing.com

Tesla received a regulatory win in Europe as the Netherlands approved its Full Self-Driving software for highways and city streets, with rollout expected shortly. Cantor Fitzgerald reiterated an Overweight rating and $510 target, while GLJ Research kept a Sell at $25.28; Tesla also pre-announced Q1 2026 deliveries of 358,023 vehicles versus 365,645 consensus and energy storage deployments of 8.8 GWh versus 14.4 GWh consensus. Shares are down 22% year-to-date ahead of April 22 earnings, even as Cybercab, Semi and Megapack 3 remain on track for volume production this year.

Analysis

The near-term read-through is not that Tesla’s European rollout suddenly justifies the equity; it is that regulatory permission meaningfully lowers the cost of capital for the FSD option value. A single-country approval in Europe is more valuable as a template than as revenue today: if the Dutch process is reproducible, the market may start discounting a broader licensing/feature-activation revenue stream 12-24 months ahead of meaningful fleet penetration.

The bigger second-order effect is competitive: this creates a policy wedge versus other OEMs that are still fighting fragmented local approvals, which could help Tesla retain pricing power even if unit growth stays muted. But the recent delivery miss plus storage shortfall matter because they weaken the bull case that software optionality can offset cyclical auto weakness immediately; that leaves the stock more dependent on narrative than fundamentals into earnings.

On the other side, China EV export strength and the German registration bounce imply the competitive overhang is getting more global, not less. That is most dangerous for legacy OEMs like Stellantis: if Chinese brands keep exporting aggressively while European regulation opens the door for higher-feature ADAS, the mid-market incumbents face a squeeze from both ends — product differentiation at the top and price pressure at the bottom.

Contrarian setup: consensus is likely overemphasizing the headline FSD approval and underweighting the lag between regulatory permission and monetization. The stock can react sharply on each new country approval, but the trade is vulnerable if earnings commentary reveals that Europe is still a long-dated rollout with limited near-term attach rates. That creates a classic event-driven / fade setup into the April 22 print.

Key Decisions for Investors

• TSLA: tactical long only into additional EU approval headlines, but use tight risk controls; best expressed via 2-4 week call spreads rather than stock, since monetization is a 12-24 month story and near-term delivery/storage fundamentals are weak.
• TSLA: fade strength into earnings with a short-dated put spread if the stock rallies on FSD optimism; risk/reward favors downside if management does not quantify Europe as a meaningful 2026 contributor.
• STLA: underweight / short versus a basket of European and US OEMs for 1-3 months; the risk is rising EV feature competition from both China and Tesla while Stellantis likely lacks pricing power to absorb it.
• UBS: use as a hedged beneficiary of the China EV export theme via short-duration risk reversal on a European auto-industry weakener only if macro risk-off persists; otherwise keep exposure light because the signal is more negative for autos than directly positive for UBS.
• Pair trade: long TSLA / short STLA on a 6-12 month horizon if you want to own the regulatory optionality while fading the legacy OEM margin compression; stop if EU adoption remains slower than one additional country per quarter.